Tsumura & Co TSMRF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $23.20
- Day Range
- $25.86–25.86
- 52-Week Range
- $18.10–25.86
- Bid/Ask
- $23.90 / $24.68
- Market Cap
- $1.96 Bil
- Volume/Avg
- 120 / 208
Key Statistics
- Price/Earnings (Normalized)
- 16.36
- Price/Sales
- 1.86
- Dividend Yield (Trailing)
- 1.81%
- Dividend Yield (Forward)
- 0.01%
- Total Yield
- 2.32%
Company Profile
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 4,736
- Website
- http://www.tsumura.co.jp
Comparables
Valuation
|
Metric
|
TSMRF
|
4554
|
4577
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.36 | 7.56 | 12.95 |
Price/Book Value | 1.02 | 0.90 | 0.76 |
Price/Sales | 1.86 | 0.91 | 0.87 |
Price/Cash Flow | 10.91 | 3.91 | 6.23 |
Price/Earnings
TSMRF
4554
4577
Financial Strength
|
Metric
|
TSMRF
|
4554
|
4577
|
|---|---|---|---|
Quick Ratio | 2.61 | 0.68 | 0.82 |
Current Ratio | 4.84 | 1.46 | 2.29 |
Interest Coverage | 65.66 | 55.27 | 197.65 |
Quick Ratio
TSMRF
4554
4577
Profitability
|
Metric
|
TSMRF
|
4554
|
4577
|
|---|---|---|---|
Return on Assets (Normalized) | 6.00% | 3.39% | 5.80% |
Return on Equity (Normalized) | 9.39% | 7.02% | 8.27% |
Return on Invested Capital (Normalized) | 6.61% | 4.22% | 7.32% |
Return on Assets
TSMRF
4554
4577
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Flbfmblshp | Rqrbmy | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Qghflzypdz | Mrxp | $68.3 Bil | |
HLN
| Haleon PLC ADR | Zktmlhr | Jyks | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Dxcnfxyd | Zbhb | $14.5 Bil | |
VTRS
| Viatris Inc | Rzcdzlqgp | Lqv | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xdcryxtq | Nytc | $11.9 Bil | |
CTLT
| Catalent Inc | Sfdltyhvg | Wwkgrk | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Jqshwlx | Qjrv | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Ngggpqm | Fntl | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Yptbzrkbq | Xznfcq | $3.5 Bil |